The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation With Tamoxifen and Letrozole for Embryo Cryopreservation
Abstract
Purpose: To develop safe ovarian stimulation methods to perform in vitro fertilization (IVF) in breast cancer patients who wish to preserve their fertility via embryo cryopreservation before chemotherapy. Patients and Methods: Sixty women (age range, 24 to 43 years) with breast cancer were prospectively studied. Twenty-nine patients underwent 33 ovarian stimulation cycles with either tamoxifen 60 mg/d alone (Tam-IVF) or in combination with low-dose follicle-stimulating hormone (TamFSH-IVF) or letrozole 5 mg in combination with FSH (Letrozole-IVF). After IVF, all resultant embryos were cryopreserved to preserve fertility. Recurrence rates were compared with controls (n = 31) who elected not to undergo IVF. Results: Compared with Tam-IVF, both TamFSH-IVF and Letrozole-IVF patients had greater numbers of follicles (2 ± 0.3 v 6 ± 1 and 7.8 ± 0.9, respectively; P < .0001), mature oocytes (1.5 ± 0.3 v 5.1 ± 1.1 and 8.5 ± 1.6, respectively; P < .001), and embryos (1.3 ± 0.2 v 3.8 ± 0.8 and 5.3 ± 0.8, respectively; P < .001). Peak estradiol (E 2) levels were lower with Letrozole-IVF and Tam-IVF compared with TamFSH-IVF. After 554 ± 31 days (range, 153 to 1,441 days) of follow-up, cancer recurrence rate was similar between IVF and control patients (three of 29 v three of 31 patients, respectively; hazard ratio, 1.5; 95% CI, 0.29 to 7.4), and this estimate was not affected by cancer stage. Conclusion: The combination of low-dose FSH with tamoxifen (TamFSH-IVF) or letrozole (Letrozole-IVF) results in higher embryo yield compared with Tam-IVF. Recurrence rates do not seem to be increased, but the letrozole protocol may be preferred because it results in lower peak E 2 levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Aromatase Inhibitors in Breast Cancer
Smith, I. E., & Dowsett, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023246 · Cited by 905
Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
Bines, J., Oleske, D. M., & Cobleigh, M. A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1718 · Cited by 816
Mouridsen, H., Gershanovich, M., Sun, Y., Pérez-Carrión, R., Boni, C., Monnier, A., Apffelstaedt, J., Smith, R., Sleeboom, H. P., Jaenicke, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.194 · Cited by 746
Risk of Menopause During the First Year After Breast Cancer Diagnosis
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M., & Hood, N. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2365 · Cited by 606
Ovarian Function after Transplantation of Frozen, Banked Autologous Ovarian Tissue
Oktay, K., & Karlikaya, G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422516 · Cited by 567
Self-citationEffect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata
Jordan, V. C. (1976) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(76)90030-x · Cited by 371
Oktay, K. (2001) · JAMA · doi:10.1001/jama.286.12.1490 · Cited by 354
Self-citationHARPER, M. J. K., & WALPOLE, A. L. (1966) · Nature · doi:10.1038/212087a0 · Cited by 327
Effect of estrogen deprivation on the reproductive physiology of male and female primates
Shetty, G., Krishnamurthy, H., Krishnamurthy, H. N., Bhatnagar, A. S., & Moudgal, R. N. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80008-8 · Cited by 306
Oktay, K., Buyuk, E., Davis, O., Yermakova, I., Veeck, L., & Rosenwaks, Z. (2003) · Human Reproduction · doi:10.1093/humrep/deg045 · Cited by 270
Self-citationKlijn, J. G. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.903 · Cited by 248
Tamoxifen treatment and gynecologic side effects: a review
MOURITS, M. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01196-0 · Cited by 200
Palermo, G. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540230043033 · Cited by 161
Rabinovici, J., Blankstein, J., Goldman, B., RUDAK, E., DOR, Y., Pariente, C., Geier, A., Lunenfeld, B., & Mashiach, S. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-693 · Cited by 129
New Synthetic Agent for the Induction of Ovulation: Preliminary Trials in Women
Klopper, A. I., & Hall, M. (1971) · BMJ · doi:10.1136/bmj.1.5741.152 · Cited by 129
Pfister, C. U., Martoni, A., Zamagni, C., Lelli, G., De Braud, F., Souppart, C., Duval, M., & Hornberger, U. (2001) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.273 · Cited by 101
Aromatase inhibitors in ovulation induction
(2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-823028 · Cited by 87
Bausero, P., Ben-Mahdi, M. H., Mazucatelli, J.-P., Bloy, C., & Perrot‐Applanat, M. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.5.h2033 · Cited by 84
Zelinski, M. B., Hess, D. L., Wolf, D. P., & Stouffer, R. L. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56771-5 · Cited by 69
Cited by
Loren, A. W., Mangu, P. B., Beck, L. N., Brennan, L., Magdalinski, A. J., Partridge, A. H., Quinn, G., Wallace, W. H., & Oktay, K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.2678 · Cited by 1,611
Self-citationPeccatori, F. A., Azim, H. A., Orecchia, R., Hoekstra, H. J., Pavlidis, N., Kesic, V., & Pentheroudakis, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt199 · Cited by 790
Preservation of Fertility in Patients with Cancer
Jeruss, J. S., & Woodruff, T. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801454 · Cited by 583
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Macklon, N. S., Stouffer, R. L., Giudice, L. C., & Fauser, B. C. J. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0015 · Cited by 562
Azim, A. A., Costantini-Ferrando, M., & Oktay, K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8700 · Cited by 480
Self-citation
Metadata
- Authors
- Oktay, K., Buyuk, E., Libertella, N., Akar, M., & Rosenwaks, Z.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-07-01
- Volume
- 23
- Issue
- 19
- Pages
- 4347-4353
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2151996914
- Cited by
- 528
- References
- 21
- FWCI
- 26.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.